Benzinga | Aug 12, 2021 09:14AM EDT

Aridis Pharmaceuticals Q2 EPS $(0.49) Down From $(0.47) YoY, Sales $33.00K Down From $1.00M YoY

Aridis Pharmaceuticals (NASDAQ:ARDS) reported quarterly losses of $(0.49) per share. This is a 4.26 percent decrease over losses of $(0.47) per share from the same period last year. The company reported $33.00 thousand in sales this quarter. This is a 96.70 percent decrease over sales of $1.00 million the same period last year.